Articles

LIGHT OF HOPE FOR STUDENTS AFTER PHARMA, BIOTECH, HEALTHCARE & LIFE SCIENCES DEGREES

Students opt for Pharma, Healthcare, Nutrition, and Food Industries when they are interested to become either a part of medicine and food research respectively apart from being a doctor. However, after the completion of such degrees, many students like you, struggled to choose their career as most fresh passouts are not aware about all the career options and growth in Pharma, Healthcare and Food Industries. The career scenario is changing very fast these days. A student has numerous options to start his/her career in the industry after being enrolled in numerous programmes which you may have never heard about earlier. IGMPI presents a unique technology enabled platform for training in these areas which is imparted in classroom as well as Distance cum eLearining modes.

Stigma - the other enemy people face in the battle against COVID-19

ABOUT AUTHOR
Dr. Sheenu Jain
Associate Professor
IIHMR University, Jaipur

World is anxiously waiting to see The-end of Corona virus; we are struggling to regain the sense of control we lost to this threat.  COVID-19 will be remembered as a disease that divided us and affecting us much harder than we imagined.

ADVANCES IN HOSPITAL PHARMACY SERVICES: AN OVERVIEW

ABOUT AUTHOR
Dr. R. S. Thakur
Email: drramsthakur@gmail.com
Phone: +91-9740802164

Preamble
Health has direct impact on socio-economic growth of the country and welfare of its people. Hospital Pharmacy of a Hospital or other Health Care Facilities makes available drugs, devices, and other materials used in the diagnosis, mitigation, prevention and treatment of injury, illness, and disease. Hospital Pharmacy procures, stores and supplies medicines for dispensing, compounding, distribution and provides Pharmaceutical Care. Talking from a patient’s perspective, hospital pharmacy services provide medicines, information and advice to inpatients and outpatients as well as to the health professionals and others giving health care to the patients. 

Diabetic nephropathy : A Review

ABOUT AUTHORS
Navneet Kaur1, Latika Khosla2
1Department of Biotechnology, CT Institute of Pharmaceutical Sciences, Shahpur, Jalandhar-144001, Punjab.
2Department of Biotechnology, Kanya Maha Vidyalaya, Jalandhar-144004, Punjab

ABSTRACT
Diabetic nephropathy (DN) is defined as a progressive pathological condition of the kidney caused by angiopathy of glomerular capillaries. The angiopathy of these capillaries is characterized by a progressive loss of glomerular filtration surface areas and capillary volume. DN is the leading cause of end-stage renal disease, and a major contributing factor to morbidity and mortality of diabetic patients throughout the world.

HIGH PERFORMANCE ENVIRONMENT FRIENDLY WATER-BASED HEAT SEAL COATING FOR PTP

ABOUT AUTHOR
Abhineet Shrivastava
1, Soumyanath Mishra2
1 Manager, Overseas business development department Coating and Engineering material division, Mitsui Chemicals Inc
2 Head, Packaging development, Mankind Pharmaceutical Ltd.

Environment pollution : Case of China and what India can learn from it

As global economy is growing, the problem of environment pollution is also increasing rapidly and now it cannot be overlooked anymore. Indeed it is imperative for countries globally to restore their ecological environment. In 2016 the World health Organization (WHO) released a report on atmospheric pollution. In this report it is said that 92% of the world’s population are exposed to atmospheric pollution of hazardous level. Data from International Energy Agency (IEA) also shows that in 2016 , 6.5 million died as a result of atmospheric pollution. One of the cause for atmospheric pollution is the use of organic solvents during industrial production. Therefore, a matter that urgently needs to be addressed is the reduction of use of organic solvent in order to reduce VOC emission.

CHALLENGES FOR FDA WITH FOREIGN INSPECTIONS

As per analysis of United States Government Accountability Office (GAO), preliminary analysis of Food and Drug Administration (FDA) data shows that from fiscal year 2012 through 2016, the number of foreign drug manufacturing establishment inspections increased. From fiscal year 2016 through 2018, both foreign and domestic inspections decreased by about 10 percent and 13 percent, respectively.

Highest Pharmaceutical mergers and acquisitions of 2019

Mergers and acquisitions (M&As) are perpetual part of big pharmaceutical industries and we have witnessed many such mergers and acquisitions. The financial crisis and resulting uncertainty in the global economies has made it difficult for companies to predict future performance of their own or their target’s or to forecast synergies and other transaction benefits with the same level of confidence seen in the past. As a result, acquirors and targets have developed transaction structures that are aimed at bridging gaps in their respective assessments of valuation and risk.

This article is focusing on top Pharmaceutical M&As of the year 2019.

Metabolic Syndrome : A Review

ABOUT AUTHOR
Navneet Kaur1, Narinder Singh2, Daisy Sharma2.
1Department of Biotechnology, CT Institute of Pharmaceutical Sciences, Shahpur, Jalandhar-144001, Punjab.
2Department of Pharmaceutics, CT Institute of Pharmaceutical Sciences, Shahpur, Jalandhar-144001, Punjab

ABSTRACT
Metabolic syndrome is defined by a group of interconnected physiological and a few biochemical or clinical disorder which directly affect the high risk rate of diseases such as cardiovascular disease (hypertension) also causing type 2 diabetes mellitus and mortality. The metabolic syndrome is higher prevalence in Western counterparts other than the urban population of some emerging countries. In the review Definition of syndrome, pathophysiology, and some criteria would be proposed for the clinical diagnosis and underlying management approaches for metabolic syndrome.

Pages